Antibody-targeted polymer-bound drugs
- PMID: 8763151
- DOI: 10.1007/BF02814745
Antibody-targeted polymer-bound drugs
Abstract
Drug targeting is an attractive new approach to killing cancer cells while leaving normal tissue unharmed. Recently we have developed a new generation of antibody-targeted immunosuppressive (cyclosporin A) and cytostatic (daunomycin, doxorubicin) drugs and photosensitizers (chlorin e6) effective in vitro and in vivo. The drugs and the targeting antibody (polyclonal and monoclonal) are conjugated to the oligopeptidic side chains of a water-soluble synthetic carrier, copolymer of N-(2-hydroxypropyl)methacrylamide. The composition of the side chains ensures the stability of the linkage between the drug and the polymeric carrier in the bloodstream and its intralysosomal degradability which is a prerequisite for the pharmacological activity of the preparation. Antibody-targeted polymer bound drugs show considerably decreased hepatotoxicity, cardiotoxicity, myelotoxicity and nephrotoxicity. Two adriamycin-HPMA copolymers are in Phase I/II clinical trials in United Kingdom.
Similar articles
-
Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.J Control Release. 2001 Jul 6;74(1-3):249-53. doi: 10.1016/s0168-3659(01)00325-x. J Control Release. 2001. PMID: 11489502
-
Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody.Clin Immunol Immunopathol. 1988 Jan;46(1):100-14. doi: 10.1016/0090-1229(88)90010-4. Clin Immunol Immunopathol. 1988. PMID: 2891460
-
Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice.Cancer Res. 1996 Sep 1;56(17):3980-5. Cancer Res. 1996. PMID: 8752167
-
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.Curr Pharm Biotechnol. 2003 Oct;4(5):311-22. doi: 10.2174/1389201033489711. Curr Pharm Biotechnol. 2003. PMID: 14529421 Review.
-
Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.Cancer Treat Rev. 1987 Dec;14(3-4):319-27. doi: 10.1016/0305-7372(87)90024-7. Cancer Treat Rev. 1987. PMID: 3326668 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources